We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

35 hedge funds and large institutions have $13M invested in Cognition Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

9% more funds holding

Funds holding: 32 → 35 (+3)

0.15% less ownership

Funds ownership: 24.4% → 24.25% (-0.15%)

6% less capital invested

Capital invested by funds: $13.8M → $13M (-$812K)

Holders
35
Holders Change
+3
Holders Change %
+9.38%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KAS
Kestra Advisory Services
Texas
+$167K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$114K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$53K
4
BlackRock
BlackRock
New York
+$43.8K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$37.7K

Top Sellers

Rank Fund Capital Flow
1
VC
Voss Capital
Texas
-$211K
2
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$160K
3
RCG
Rock Creek Group
District of Columbia
-$84.2K
4
Two Sigma Investments
Two Sigma Investments
New York
-$55.9K
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$31.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFO
1
Pathstone Family Office
New Jersey
$4.04M -$10.6K -5,000 -0.2%
ACM
2
AIGH Capital Management
Maryland
$3.73M +$2.12K +1,000 +0%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.22M +$53K +25,035 +4%
WVP
4
Worth Venture Partners
New Jersey
$931K +$14.8K +7,000 +1%
CC
5
Carlson Capital
Texas
$448K -$358 -169 -0.1%
PWM
6
Perigon Wealth Management
California
$409K -$3.17K -1,500 -0.7%
AFG
7
American Financial Group
Ohio
$375K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$323K +$114K +53,900 +44%
KAS
9
Kestra Advisory Services
Texas
$318K +$167K +78,784 +83%
Commonwealth Equity Services
10
Commonwealth Equity Services
Massachusetts
$171K -$160K -75,457 -45%
BCM
11
Bridgeway Capital Management
Texas
$121K – – –
VC
12
Voss Capital
Texas
$110K -$211K -99,751 -62%
BlackRock
13
BlackRock
New York
$107K +$43.8K +20,678 +55%
FC
14
FCA Corp
Texas
$94.2K – – –
CWM
15
Castle Wealth Management
Florida
$79.4K – – –
NCM
16
Neumann Capital Management
California
$61.1K – – –
Northern Trust
17
Northern Trust
Illinois
$56.2K +$3.25K +1,538 +5%
State Street
18
State Street
Massachusetts
$55.4K – – –
HighTower Advisors
19
HighTower Advisors
Illinois
$48K -$4.23K -2,000 -7%
NFC
20
Northeast Financial Consultants
Connecticut
$44.8K – – –
BSB
21
Bangor Savings Bank
Maine
$44K +$10.6K +5,000 +26%
Baird Financial Group
22
Baird Financial Group
Wisconsin
$41K – – –
Morgan Stanley
23
Morgan Stanley
New York
$40K – – –
Bank of New York Mellon
24
Bank of New York Mellon
New York
$32.6K +$37.7K +17,795 New
Mercer Global Advisors
25
Mercer Global Advisors
Colorado
$29K +$33.8K +15,951 New
1
2

CGTX Hedge Fund Activity: Q2 2023 in Review

35 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q2 2023, worth a combined $13M — down 5.9% from $13.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CGTX positions and 3 closed out — a net gain of 3 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Kestra Advisory Services, adding an estimated $167K. The largest seller was Voss Capital, cutting an estimated $211K.

  • 35 institutional investors held Cognition Therapeutics (CGTX) as of Q2 2023, up from 32 in Q1 2023.
  • Funds reported $13M of Cognition Therapeutics stock for Q2 2023, down 5.9% quarter-over-quarter.
  • 6 funds opened new Cognition Therapeutics positions in Q2 2023 and 3 closed out, a net change of +3 holders.
  • The largest Cognition Therapeutics buyer in Q2 2023 was Kestra Advisory Services, an estimated $167K added.
  • The largest Cognition Therapeutics seller in Q2 2023 was Voss Capital, an estimated $211K sold.

Based on aggregated 13F filings for Q2 2023.